United Kingdom

China Regenerative Medicine International Ltd (8158.HK)

8158.HK on Hong Kong Stock

18 Jul 2018
Change (% chg)

-- (--)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

Chart for


China Regenerative Medicine International Limited is an investment holding company mainly engaged in the sale of medical equipments. Along with subsidiaries, the Company operates its business through four segments. The Medical Equipment segment is involved in trading of medical equipments. The Tissue Engineering segment is... (more)
No analyst recommendations are available for .


Beta: 1.77
Market Cap(Mil.): HK$3,429.23
Shares Outstanding(Mil.): 17,585.79
Dividend: --
Yield (%): --


  8158.HK Industry Sector
P/E (TTM): -- 85.36 32.76
EPS (TTM): -0.01 -- --
ROI: -- 2.21 14.61
ROE: -- 3.85 16.34

BRIEF-China Regenerative Medicine Informed That All Favour Intends To Dispose 2 Bln Shares Of Co

Jan 25 China Regenerative Medicine International Ltd:

25 Jan 2018

BRIEF-Baolingbao Biology's Unit Signs Agreement To Acquire 11.4 Pct Stake In China Regenerative Medicine

* SAYS UNIT SIGNS AGREEMENT TO BUY 2.0 BILLION SHARES IN CHINA REGENERATIVE MEDICINE INTERNATIONAL, OR 11.4 PERCENT STAKE, FOR HK$360 MILLION ($46.05 million) Source text in Chinese: http://bit.ly/2Dze5gs Further company coverage: ($1 = 7.8170 Hong Kong dollars) (Reporting by Hong Kong newsroom)

25 Jan 2018

BRIEF-China Regenerative Medicine International Says ‍Substantial Shareholder Ups Stake In Co

Jan 24 China Regenerative Medicine International Ltd:

24 Jan 2018

Earnings vs. Estimates

No consensus analysis data available.